Molecular Testing in Thyroid Cancer
0 Pogledi
• 07/01/23
0
0
Ugraditi
administrator
Pretplatnici
Panelists R. Michael Tuttle, MD; Eric J. Sherman, MD; Marcia S. Brose, MD, PhD; Naifa Busaidy, MD, FAPC, FACE; and Frank Worden, MD, discuss the present day use of molecular testing for thyroid cancer, which, for now, is largely prognostic but not predictive.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari